Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Adenosine Diphosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 known ✓ | P47900 | 9/20 | 0.78 |
| ▸ | P2RY2 known ✓ | P41231 | 3/20 | 0.78 |
| ▸ | ADORA1 known ✓ | P30542 | 1/20 | 0.77 |
| ▸ | PDE4D known ✓ | Q08499 | 1/20 | 0.77 |
| ▸ | PDE3A known ✓ | Q14432 | 1/20 | 0.77 |
| ▸ | SRC | P12931 | 2/20 | 0.78 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.78 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.78 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.78 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.78 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.78 |
| ▸ | P2RY11 | Q96G91 | 3/20 | 0.77 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.77 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.77 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.77 |
| ▸ | LDHA | P00338 | 1/20 | 0.77 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.77 |
| ▸ | FBP1 | P09467 | 1/20 | 0.77 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine Diphosphate SCHEMBL29723933 | 1.00 | P2RY1 (0.78) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Adenosine Diphosphate SCHEMBL30936667 | 0.99 | P2RY1 (0.76) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Adenosine Diphosphate SCHEMBL11579601 | 0.99 | P2RY1 (0.76) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Adenosine Diphosphate SCHEMBL29803182 | 0.99 | P2RY1 (0.76) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Adenosine Triphosphate SCHEMBL30839398 | 0.98 | P2RY1 (0.75) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Adenosine Triphosphate SCHEMBL1496269 | 0.98 | P2RY1 (0.75) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Adenosine Diphosphate SCHEMBL29444634 | 0.98 | P2RY1 (0.78) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Adenosine Diphosphate SCHEMBL28284912 | 0.98 | P2RY1 (0.78) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Adenosine Triphosphate SCHEMBL27568797 | 0.96 | P2RY1 (0.73) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 | |
| Adenosine Triphosphate SCHEMBL30819483 | 0.96 | P2RY1 (0.75) | P2RY1P2RY2SRCSMN1; SMN2P2RX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025090025-A1 | SILICON NANOCOMPOSITE ANODE | VOLT14 SOLUTIONS PTE. LTD. (SG) | 2025-05-01 | — | — | WO | claimed |
| CN-118641666-A | Method for detecting related substances of meglumine adenosine cyclophosphate injection | 贵州圣济堂制药有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-116223821-A | Platelet aggregation function detection reagent and application thereof | 上海太阳生物技术有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-114748423-A | Traditional Chinese medicine spray and spraying device | 张丽芹 | 2022-07-15 | — | — | CN | claimed |
| CN-113943702-A | Culture medium for amplifying amniotic mesenchymal stem cells and preparation method thereof | 白彩云 | 2022-01-18 | — | — | CN | claimed |
| CN-109820803-B | Composition capable of removing skin toxin and increasing skin resistance and application thereof | 东晟源研究院(广州)有限公司 | 2021-11-12 | — | — | CN | claimed |
| CN-112730769-A | Platelet aggregation functional adenosine diphosphate cup detection reagent and preparation method thereof | 郑州普湾医疗技术有限公司 | 2021-04-30 | — | — | CN | claimed |
| CN-112707966-A | Protein and hierarchical pore metal-organic framework compound and preparation method and application thereof | 华南理工大学 | 2021-04-27 | — | — | CN | claimed |
| CN-109928999-B | Boron-containing compound, pharmaceutical composition, and preparation method and application of boron-containing compound | 童永彭 | 2020-11-06 | — | — | CN | claimed |
| US-6255291-B1 | MIXTURE OF ALANINE, ADENOSINE COMPOUND, RIBOSE COMPOUND, ASCORBIC ACID AND NICOTINIC ACID | PEREGRINE PHARMACEUTICALS, INC. | 2001-07-03 | — | — | US | claimed |
| US-4844884-A | TYROSINE DERIVATIVES AND ADENOSINE-5'-PHOSPHATES | INDUCHEM AG (CH) | 1989-07-04 | — | — | US | claimed |
| US-12533371-B2 | Multilayer pharmaceutical or nutraceutical solid dosage forms comprising pyrimidine and/or purine derivatives and b vitamins, preparation and uses thereof | FERRER INTERNACIONAL, S.A. (ES) | 2026-01-27 | — | — | US | disclosed |
| WO-2025090025-A1 | SILICON NANOCOMPOSITE ANODE | VOLT14 SOLUTIONS PTE. LTD. (SG) | 2025-05-01 | — | — | WO | disclosed |
| CN-119859664-A | Preparation method of glutathione | 浙江工业大学 | 2025-04-22 | — | — | CN | disclosed |
| CN-118641666-A | Method for detecting related substances of meglumine adenosine cyclophosphate injection | 贵州圣济堂制药有限公司 | 2024-09-13 | — | — | CN | disclosed |
| US-5055304-A | Containing disodium adenosine triphosphate and low melting fat or oil-like component; cardiovascular disorders, asthenopia | SENJU PHARMACEUTICAL CO., LTD. (JP) | 1991-10-08 | — | — | US | disclosed |
| US-5017564-A | Vitamin B1 deravitive and disodium ATP | SENJU PHARMACEUTICAL CO., LTD. (JP) | 1991-05-21 | — | — | US | disclosed |
| EP-0348688-A1 | Solid pharmaceutical preparation and method of producing same | Senju Pharmaceutical Co., Ltd. (JP) | 1990-01-03 | — | — | EP | disclosed |
| EP-0344795-A1 | Stabilized pharmaceutical composition and method of producing same | Senju Pharmaceutical Co., Ltd. (JP) | 1989-12-06 | — | — | EP | disclosed |
| US-4844884-A | TYROSINE DERIVATIVES AND ADENOSINE-5'-PHOSPHATES | INDUCHEM AG (CH) | 1989-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12533371-B2 | Multilayer pharmaceutical or nutraceutical solid dosage forms comprising pyrimidine and/or purine derivatives and b vitamins, preparation and uses thereof | P2RY10, TYMP, P2RY12 | P2RY1 14/4885P2RY2 42/4885ADORA1 223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.